Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds

American Journal of Surgery

Volumn 195, Issue 6, 2008, Pages 782-788

  Apelqvist, Jan ^a,b   Armstrong, David G ^c   Lavery, Lawrence A ^d   Boulton, Andrew J M ^e,f  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY OF MIAMI   (United States)

Author keywords

Amputation; Diabetes; Infection; Resource utilization; Ulcer; Wound

Indexed keywords

ANTIBIOTIC AGENT; TOPICAL AGENT;

ADULT; AGED; AMPUTATION; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DIABETIC FOOT; DIABETIC PATIENT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INSTRUMENTATION; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VACUUM ASSISTED CLOSURE; VACUUM ASSISTED CLOSURE SYSTEM; WOUND CARE; WOUND DRESSING;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANTI-BACTERIAL AGENTS; BANDAGES; DIABETIC FOOT; FEMALE; FOOT; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEGATIVE-PRESSURE WOUND THERAPY; WOUND HEALING;

EID: 44349193355     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.06.023     Document Type: Article

References (25)

1. Ramsey S.D., Newton K., Blough D., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22 (1999) 382-387
2. Ragnarson Tennvall G., and Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis 39 suppl 2 (2004) S132-S139
3. Armstrong D.G., Lavery L.A., and Harkless L.B. Validation of a diabetic wound classification system: the contribution of depth, infection, and vascular disease to the risk of amputation. Diabetes Care 21 (1998) 8559
4. Apelqvist J. Wound healing in diabetes. Outcome and costs. Clin Podiatr Med Surg 15 (1998) 21-39
5. Apelqvist J., Ragnarson-Tennval G., Persson U., et al. Diabetic foot ulcers in a multidisciplinary setting- an economic analysis of primary healing and healing with amputation. J Intern Med 235 (1994) 463-471
6. Tennvall G.R., Apelqvist J., and Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 18 (2000) 225-238
7. Ragnarson Tennvall G., and Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 14 (2000) 235-241
8. Boulton A.J., Vileikyte L., Ragnarson-Tennvall G., et al. The global burden of diabetic foot disease. Lancet 366 (2005) 1719-1724
9. Ghatnekar O., Persson U., Willis M., et al. Cost effectiveness of becaplermin in the treatment of diabetic foot ulcers in four european countries. Pharmacoeconomics 19 (2001) 767-778
10. Ghatnekar O., Willis M., and Persson U. Cost-effectiveness of treating deep diabetic foot ulcers with promogran in four european countries. J Wound Care 11 (2002) 70-74
11. Redekop W.K., McDonnell J., Verboom P., et al. The cost effectiveness of Apligraf treatment of diabetic foot ulcers. Pharmacoeconomics 21 (2003) 1171-1183
12. Allenet B., Paree F., Possnett J., et al. Cost-effectiveness of Dermagraftr for the treatment of diabetic foot ulcers in France. Diabetologia 42 suppl 1 (1999) A308
13. Persson U., Willis M., Odegaard K., et al. The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data. Value Health 3 suppl 1 (2000) 39-46
14. Treweek S., and James P.B. A cost analysis of monoplace hyperbaric oxygen therapy with and without recirculation. J Wound Care 15 (2006) 235-238
15. Armstrong D.G., and Lavery L.A. Negative pressure wound after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366 (2005) 1704-1710
16. Armstrong D.G., Attinger C.E., Boulton A.J., et al. Guidelines regarding negative wound therapy (NPWT) in the diabetic foot. Ostomy Wound Manage 50 suppl 4B (2004) 3S-27S
17. Sibbald R.G., and Mahoney J. A consensus report on the use of vacuum-assisted closure in chronic, difficult-to-heal wounds. Ostomy Wound Manage 49 (2003) 52-66
18. Joseph E., Hamori C.A., Bergman S., et al. A prospective randomized trial of vacuum-assisted closure versus standard therapy of chronic nonhealing wounds. Wounds 12 (2002) 60-67
19. McCallon S.K., Knight C.A., Valiulus J.P., et al. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage 46 (2000) 282
20. Moues C.M., van den Bemd G.J., Meerding W.J., et al. An economic evaluation of the use of TNP on full-thickness wounds. J Wound Care 14 (2005) 224-227
21. Braakenburg A., Obdeijn M.C., Feitz R., et al. The clinical efficacy and cost effectiveness of the vacuum-assisted closure technique in the management of acute and chronic wounds: a randomized controlled trial. Plast Reconstr Surg 118 (2006) 390-397
22. Wound Ostomy Continence Nursing Society. Guideline for Management of Wounds in Patients With Lower-Extremity Neuropathic Disease (2004), WOCN, Glenview, IL 57
23. Armstrong D.G., Attinger C.E., Boulton A.J.M., et al. Guidelines regarding negative pressure wound therapy in the diabetic foot: results of the Tucson Expert Consensus Conference. Ostomy Wound Manage 50 suppl 4B (2004) 3S-27S
24. Armstrong D.G., Lavery L.A., Abu-Rumman P., et al. Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot. Ostomy Wound Manage 48 (2002) 64-68
25. Hersh R.E., Jack J.M., Dahman M.I., et al. The vacuum-assisted closure device as a bridge to sternal wound closure. Ann Plast Surg 46 (2001) 250-254